EGFR and hepatocellular carcinoma: identified that DNA hypermethylation‐activated full‐length EMX1 binds to the Epidermal Growth Factor Receptor (EGFR) promoter, enhancing EGFR transcription and activating the EGFR‐extracellular signal‐regulated kinase (ERK) signalling pathway, significantly promoting HCC metastasis.183